Advertisement
Advertisement
TSHA
Taysha Gene Therapies, Inc. Common Stock
6.46
USDSponsored
+0.03
+0.47%
Apr 20, 16:00 UTC -4
Closed
Pre-Market
6.33
-0.13
-2.09%
Taysha Gene Therapies, Inc. Common Stock Financial Snapshot
| Market Cap | 1.82B |
| Beta | 1.10 |
| Earnings Per Share (EPS) | -0.34 |
| Price-to-Book (P/B) Ratio | 5.14 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 20.29% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -56.64% |
| Current Ratio | 12.23% |
| Free Cash Flow | -93.83M |
Trending Stocks
Advertisement